Subscribe to RSS
DOI: 10.1055/s-0030-1265162
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Glycaemic Rises after Waking Up in Response to an Alarm Clock in Type 1-diabetic Patients Analysed with Continuous Glucose Monitoring (GlucoDay® S)
Publication History
received 14.04.2010
first decision 08.08.2010
accepted 24.08.2010
Publication Date:
18 January 2011 (online)

Abstract
Aims: Waking up in response to an alarm-clock may evoke a stress reaction that leads to rising glucose concentrations.
Method: 30 type 1-diabetic patients participated in 3 overnight conditions: (a) with an alarm-clock set at 2 h intervals for glucose self monitoring, (b) with a nurse performing blood glucose determinations, and (c) with the patients left undisturbed. Continuous glucose monitoring (CGM) was performed with a GlucoDay® S device.
Results: After waking up in response to an alarm-clock, CGM-determined glucose concentrations rose by 18±6 mg/dl at 4 a.m. (p=0.0003), whereas negligible increments were seen with nurse assistance (e. g., 0±4 mg/dl at 4 a.m.).
Conclusions: Waking up in response to an alarm-clock leads to an arousal reaction that causes significant elevations in glucose concentrations. Continuous glucose monitoring is a suitable method to detect such short-lived increments in glucose concentrations. But at the moment the CGMS is not able to substitute for inpatient glucose profiles. Registered with ClinicalTrials.gov, Identification number NCT00740012.
Key words
glucose profiles - night profiles - basal insulin - stress - arousal - continuous glucose monitoring
References
- 1
Berndt C, Köthe L, Nawrodt B. et al .
Glycaemic rises after waking up in response to an alarm clock during the night in
type 1-diabetic patients can be avoided by experienced nurses drawing blood in a hospital
setting as shown by continuous glucose monitoring (GlucoDay) (abstract 14).
Diabetologia.
2008;
51
(Suppl. 1)
S12
MissingFormLabel
- 2
DeVries JH, Wentholt IM, Masurel N. et al .
Nocturnal hypoglycaemia in type 1 diabetes – consequences and assessment.
Diabetes Metab Res Rev.
2004;
20
(Suppl. 2)
S43-S46
MissingFormLabel
- 3
Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B.
Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous
Glucose Monitoring System (CGMS) in daily life.
Diabet Med.
2005;
22
858-862
MissingFormLabel
- 4
Jones TW, Porter P, Sherwin RS. et al .
Decreased epinephrine responses to hypoglycemia during sleep.
N Engl J Med.
1998;
338
1657-1662
MissingFormLabel
- 5
Kaufman FR, Austin J, Neinstein A. et al .
Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric
patients with type 1 diabetes.
J Pediatr.
2002;
141
625-630
MissingFormLabel
- 6
Lepore M, Pampanelli S, Fanelli C. et al .
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human
insulin analog glargine, NPH insulin, and ultralente human insulin and continuous
subcutaneous infusion of insulin lispro.
Diabetes.
2000;
49
2142-2148
MissingFormLabel
- 7
Maran A, Crepaldi C, Tiengo A. et al .
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.
Diabetes Care.
2002;
25
347-352
MissingFormLabel
- 8
Trinder J, Allen N, Kleiman J. et al .
On the nature of cardivascular activation at an arousal from sleep.
Sleep.
2003;
26
543-551
MissingFormLabel
Correspondence
Prof. Dr. med. M. A. Nauck
Diabeteszentrum Bad
Lauterberg
Kirchberg 21
37431 Bad Lauterberg im Harz
Germany
Phone: +49/5524/81218
Fax: +49/5524/81398
Email: M.Nauck@diabeteszentrum.de